Resumen
Background and Purpose - Spreading depolarizations (SDs) may contribute to delayed cerebral ischemia after subarachnoid hemorrhage (SAH). We tested whether SD-inhibitor valproate reduces brain injury in an SAH rat model with and without experimental SD induction. Methods - Rats were randomized in a 2×2 design and pretreated with valproate (200 mg/kg) or vehicle for 4 weeks. SAH was induced by endovascular puncture of the right internal carotid bifurcation. One day post-SAH, brain tissue damage was measured with T 2 -weighted magnetic resonance imaging, followed by cortical application of 1 mol/L KCl (to induce SDs) or NaCl (no SDs). Magnetic resonance imaging was repeated on day 3 followed by histology to confirm neuronal death. Neurological function was measured with an inclined slope test. Results - In the groups with KCl application, lesion growth between days 1 and 3 was 57±73 mm3 in the valproate-treated versus 237±232 mm3 in the vehicle-treated group. In the groups without SD induction, lesion growth in the valproate- and vehicle-treated groups was 8±20 mm3 versus 27±52 mm3. On fitting a 2-way analysis of variance model, we found a significant interaction effect between treatment and KCl/NaCl application of 161 mm3 (P=0.04). Number and duration of SDs, mortality, and neurological function were not statistically significantly different between groups. Lesion growth on magnetic resonance imaging correlated to histological infarct volume (Spearman's rho =0.83; P=0.0004), with areas of lesion growth exhibiting reduced neuronal death compared with primary lesions. Conclusions - In our rat SAH model, valproate treatment significantly reduced brain lesion growth after KCl application. Future studies are needed to confirm that this protective effect is based on SD inhibition.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 452-458 |
| Número de páginas | 7 |
| Publicación | Stroke |
| Volumen | 48 |
| N.º | 2 |
| DOI | |
| Estado | Published - feb 1 2017 |
Nota bibliográfica
Publisher Copyright:© 2016 American Heart Association, Inc.
Financiación
Sources of Funding Netherlands Organization for Scientific Research (Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie [ZonMW] Veni grant), the Netherlands Heart Foundation (2011T055), and the Netherlands Brain Foundation (project 2011(1)-102) (Dr Wermer). This work was partly supported by the Utrecht University High Potential Program (Dr Dijkhuizen) and the EU Marie Curie IAPP Program "BRAINPATH" (nr 612360; Dr van den Maagdenberg) and the American Heart Association 14SDG18410020 (Dr Stowe).
| Financiadores | Número del financiador |
|---|---|
| Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie | |
| Netherlands Brain Foundation | |
| Netherlands Heart Foundation | 2011T055 |
| American the American Heart Association | 14SDG18410020 |
| American the American Heart Association | |
| H2020 Marie Skłodowska-Curie Actions | 612360 |
| H2020 Marie Skłodowska-Curie Actions | |
| ZonMw Memorabel | |
| Universiteit Utrecht | |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek |
ASJC Scopus subject areas
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
- Advanced and Specialized Nursing
Huella
Profundice en los temas de investigación de 'Valproate Reduces Delayed Brain Injury in a Rat Model of Subarachnoid Hemorrhage'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver